DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,572 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,865,979 | -5.0% | 23,478 | -5.0% | 0.40% | -12.2% |
Q1 2024 | $6,173,328 | +2.6% | 24,721 | -4.9% | 0.45% | -7.2% |
Q4 2023 | $6,015,997 | -6.3% | 26,005 | +0.5% | 0.49% | -15.8% |
Q3 2023 | $6,420,828 | +3.7% | 25,880 | +0.3% | 0.58% | +22.5% |
Q2 2023 | $6,190,320 | -2.6% | 25,793 | +2.3% | 0.47% | -11.3% |
Q1 2023 | $6,352,669 | -4.7% | 25,205 | +0.3% | 0.53% | -18.7% |
Q4 2022 | $6,668,943 | +5.2% | 25,126 | +2.3% | 0.65% | -9.9% |
Q3 2022 | $6,341,000 | +1.7% | 24,552 | -0.1% | 0.72% | +2.8% |
Q2 2022 | $6,232,000 | -13.2% | 24,581 | +0.4% | 0.70% | -1.7% |
Q1 2022 | $7,182,000 | -9.3% | 24,484 | +1.7% | 0.72% | -8.1% |
Q4 2021 | $7,921,000 | +6.0% | 24,075 | -2.0% | 0.78% | -5.7% |
Q3 2021 | $7,476,000 | +4.2% | 24,557 | -8.2% | 0.83% | +0.7% |
Q2 2021 | $7,176,000 | +20.7% | 26,739 | +1.2% | 0.82% | +7.7% |
Q1 2021 | $5,946,000 | +1.8% | 26,419 | +0.5% | 0.76% | -23.0% |
Q4 2020 | $5,841,000 | -0.8% | 26,294 | -0.9% | 0.99% | -12.6% |
Q3 2020 | $5,891,000 | +12.0% | 26,531 | -7.3% | 1.13% | -4.6% |
Q2 2020 | $5,258,000 | +23.7% | 28,629 | +4.9% | 1.18% | +3.6% |
Q1 2020 | $4,251,000 | -1.3% | 27,280 | -1.0% | 1.14% | +8.2% |
Q4 2019 | $4,307,000 | +14.2% | 27,560 | +0.3% | 1.06% | +1.5% |
Q3 2019 | $3,771,000 | -0.6% | 27,488 | +3.1% | 1.04% | +1.1% |
Q2 2019 | $3,792,000 | +8.6% | 26,653 | +1.1% | 1.03% | -3.2% |
Q1 2019 | $3,492,000 | +11.8% | 26,368 | -6.0% | 1.06% | +8.7% |
Q4 2018 | $3,123,000 | – | 28,044 | – | 0.98% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |